1/69
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
PLT size
9-13 fl
what is the job of the glycocalyx
Their function is to protect the platelet, aid in adhesion, and plays a role in immune regulation.
what kinds of granules are in PLTs
alpha granules
dense granules
dense granule materials
ADP
ATP
Calcium
Magnesium
serotonin
What are the 3 Steps in Primary Hemostasis?
Adhesion
Aggregation
Secretion
What are the 4 stages of platelets in Primary Hemostasis?
Endothelial Injury
Exposure
Activation
Aggregation
Please list the 5 items that are secreted by activated platelets
Serotonin
Calcium
Thromboxane
Von Willebrand factor
ADP
main receptor on PLT for primary hemostasis
GP1b
what does thrombin do (4)
Activating PLT
Cleaves fibrinogen to fibrin
Cleaves stabilizing factor
Activated cofactors
List the 4 key anticoagulants (naturally occurring)
Antithrombin III
Heparin Cofactor HCII
Protein C and Protein S (PC,PS)
Cell regulators
Who releases tPA?
Normal healthy cells release small amounts of tPA naturally
What is the stimulus for tPA release?
When healthy tissue is exposed to FX and thrombin they are stimulated to produce more tPA
fibrinolytic cascade
fibrin polymer + XIIIa leads to cross linked fibrin clot
PAi turns to tPA.
tPA cleaves plasminogen to plasmin
plasmin degrades the crosslinked fibrin clot
How does Heparin work?
Heparin indirectly inhibits clotting factors by binding to and increasing the activity of ATIII (antithrombin III)
Is heparin a direct thrombin inhibitor or a FX inhibitor?
FX inhibitor
how does aspirin work
blocks the synthesis of thromboxane A2 which means the enzyme cannot produce thromboxane. Targets the activation step
how do ADP receptors inhibitors work
blocks PLT aggregation by interfering with ADP which blocks GPIIB/IIIA expression. Blocks aggregation. Targets the activation step
how do GPIIB/IIIA inhibitors work?
antibodies that bind to the GPIIB/IIIA receptor which prevents the PLT from crosslinking with fibrinogen and other platelets. Targets the aggregation step.
INR calculation
(PTtest / PTnormal) ^ISI
Where do you find the ISI?
ISI is found in the standards set by each manufacturer or lab for the tissue factor. This allows comparison of tissue factor from batch to batch
what do TEG/TEM test?
Tests for extrinsic pathway, intrinsic pathway, fibrinogen, clotting time, strength of clotting, and how the clot is lysed.
when is TEG/TEM useful?
cardiothoracic patients to see what they need from the blood that they receive from the blood bank.
Helpful in cases of large blood volume loss and clotting issues to inform what product to give the patient.
More commonly used in emergency medicine when we don't have much time.
A Platelet function screen is useful for identifying what types of coagulopathies?
Abnormal results may indicate Von Willebrand disease, Glanzmann's, or Bernard Soulier disease. Tells us the patient has a platelet disease!
What are some KEY symptoms of Primary Hemostatic Problems?
Pethechiae
Anterior epistaxis
Prolonged bleeding time
Decreased PLT number
Decreased PLT function
What are KEY symptoms of Secondary Hemostatic Problems?
Ecchymoses
Deep tissue hematoma
Posterior epistaxis
Prolonged PT
Prolonged PTT
Decreased clotting factors
main symptoms of vWD
Mucocutaneous bleeding
Deep tissue bleeding
difference between type 1 and type 2 vWD
Type 1: low number vWF
Type 2: abnormal number of vWF and abnormal function
vWD PLT aggregation study
decreased
Bernard Soulier: What is the deficiency here?
Deficiency or absence of PLT receptor (Gp1b)
Glanzmann Thrombasthenia: what is the deficiency here?
GP2b3a
Uremic Platelet Dysfunction: what organ is at fault here?
kidney
what gene is responsible for TTP
ADMTS-13
symptoms of TTP
Thrombocytopenia (low PLT)
Microangiopathic hemolytic anemia (MAIHA)
Fever
Renal insufficiency (hematuria, decreased urine output)
Neurological issues (headache and confusion)
what would we see on a blood smear from a patient with TTP
schistocytes due to MAIHA
how are DIC and TTP similar
both can result in MAIHA
how are DIC and TTP different
DIC PT and PTT are prolonged
TTP PT and PTT are normal
common lab values in DIC
Prolonged PT and PTT
Thrombocytopenia
MAIHA
Decreased fibrinogen
Increased D-Dimer
pattern of clotting and bleeding for DIC
Initially the patient is more likely to clot
Later the patient is more likely to bleed.
etiology of HIT
IgG Ab complexes with heparin and PLT factor 4, activating it
ITP pathogenesis
Autoantibodies that target PLT for destruction by binding to GP2b3a
Primary ITP vs Secondary ITP
Primary ITP = ITP alone
Secondary ITP = ITP triggered by Hep C, HIV, or lupus
what is the deficiency in hemophilia A
factor VIII
what is the deficiency in haemophilia B
factor IX
what is the deficiency in haemophilia C
factor XI
symptoms of haemophilia C
physical findings are relatively normal except when bleeding occurs, bruising may occur at unusual sites, pallor, fatigue, tachycardia
genetic link in haemophilia C
not X linked!
seen in both males and women
How does Liver Disease affect the coagulation process?
The liver is where coagulation factors are made except VIII
5 MAIN Thrombophilia diseases
Factor V Leiden
Prothrombin gene mutation
Protein C deficiency
Protein S deficiency
Antiphospholipid syndrome
what causes the issue with factor V leiden
autosomal dominant point mutation in the gene for factor V
what causes PC and PS deficiency
vitamin K deficiency due to warfarin
The primary inhibitor of the fibrinolytic system is:
antiplasmin
Dilute Russell's viper venom test (DRVVT) is helpful in the diagnosis of:
lupus anticoagulant
Warfarin (Coumadin) acts on what?
It acts on Vitamin K-dependent clotting factors
Protein C Function
It is a physiologic inhibitor of coagulation
Thrombin-thrombomodulin complex is necessary for:
activation of protein C
Heparin-induced thrombocytopenia is caused by:
antibody to heparin-platelet factor 4 complex
Which of the following results are correct regarding lupus inhibitors?
prolonged aPTT on undiluted plasma because the PTT pathway includes phospholipids (Anti-phos)
The APTT is sensitive to a deficiency of which clotting factor?
A. Factor VII
B. Factor X
C. PF3
D. Calcium
B. Factor X
B The APTT is sensitive to the deficiency of coagulation factors in the intrinsic pathway (factors XII, XI, IX, and VIII) and the common pathway (factors X, V, II, and I).
A patient with a prolonged PT is given intravenous vitamin K. The PT corrects to normal after 24 hours. What clinical condition most likely caused these results?
A. Necrotic liver disease
B. Factor X deficiency
C. Fibrinogen deficiency
D. Obstructive jaundice
D. Obstructive jaundice
D Obstructive jaundice contributes to coagulation disorders by preventing vitamin K absorption. Vitamin K is fat soluble and requires bile salts for absorption. Parenteral administration of vitamin K bypasses the bowel; hence the need for bile salts.
A prolonged APTT is corrected with factor VIII- deficient plasma but not with factor IX-deficient plasma. Which factor is deficient?
A. V
B. VIII
C. IX
D. X
C. IX
C Because the prolonged APTT is not corrected with a factor IX-deficient plasma, factor IX is suspected to be deficient in the test plasma.
Refer to the following results:
PT = prolonged
APTT = prolonged
Platelet count = decreased
Which disorder may be indicated?
A. Factor VIII deficiency
B. von Willebrand's disease
C. DIC
D. Factor IX deficiency
C. DIC
C In DIC, there is a diffuse intravascular generation of thrombin and fibrin. As a result, coagulation factors and platelets are consumed, resulting in decreased platelet count and increased PT and APTT.
Which of the following is a predisposing condition for the development of DIC?
A. Adenocarcinoma
B. Idiopathic thrombocytopenic purpura (ITP)
C. Post-transfusion purpura (PTP)
D. Heparin-induced thrombocytopenia (HIT)
A. Adenocarcinoma
A Adenocarcinoma can liberate procoagulant (thromboplastic) substances that can activate prothrombin intravascularly. ITP is a thrombocytopenia caused by an autoantibody; PTP is an alloimmune thrombocytopenia caused by transfusion of blood or blood products; HIT results from an antibody to heparin-PF4 complex causing thrombocytopenia in 1%-5% of patients who are on heparin therapy. In some affected persons, thrombosis may also occur.
Factor XII deficiency is associated with:
A. Bleeding episodes
B. Epistaxis
C. Decreased risk of thrombosis
D. Increased risk of thrombosis
D. Increased risk of thrombosis
D Factor XII-deficient patients commonly have thrombotic episodes. Factor XII is the contact activator of the intrinsic pathway of coagulation. It also plays a major role in the fibrinolytic system by activating plasminogen to form plasmin. Hemorrhagic manifestations are not associated with factor XII deficiency because thrombin generated by the extrinsic pathway can activate factor XI to XIa, and factor VIIa/TF can activate factor IX to IXa
The following laboratory results were obtained from a 40-year-old woman:
PT = 20 sec; APTT = 50 sec; thrombin time = 18 sec.
What is the most probable diagnosis?
A. Factor VII deficiency
B. Factor VIII deficiency
C. Factor X deficiency
D. Hypofibrinogenemia
D. Hypofibrinogenemia
D Fibrinogen (factor I) is a clotting protein of the common pathway and is evaluated by the thrombin time. In hypofibrinogenemia (fibrinogen concentration <100 mg/dL), the PT, APTT, and TT are prolonged. In factor VII deficiency, the APTT is normal; in factor VIII deficiency, the PT is normal; and in factor X deficiency, the TT is normal.
When performing a factor VIII activity assay, a patient's plasma is mixed with:
A. Normal patient's plasma
B. Factor VIII deficient plasma
C. Plasma with a high concentration of factor VIII
D. Normal control plasma
B. Factor VIII deficient plasma
B Coagulation factor assays are based upon the ability of the patient's plasma to correct any specific factor-deficient plasma. To measure for factor VIII activity in a patient's plasma, diluted patient plasma is mixed with a factor VIII-deficient plasma. An APTT test is performed on the mixture. Each laboratory should calculate its own normal ranges based on patient population, reagents, and the instrument used. An approximate range of 50%-150% is considered normal.
Refer to the following results:
PT = normal
APTT = prolonged
Bleeding time= increased
Platelet count = normal
Platelet aggregation to ristocetin = abnormal
Which of the following disorders may be indicated?
A. Factor VIII deficiency
B. DIC
C. von Willebrand's disease
D. Factor IX deficiency
C. von Willebrand's disease
C VWF is involved in both platelet adhesion and coagulation via complexing with factor VIII. Therefore, in von Willebrand's disease (deficiency or functional abnormality of VWF) factor VIII is also decreased, causing an abnormal APTT as well as abnormal platelet aggregation to ristocetin. The platelet count and the PT are not affected in VWF deficiency
Fibrin monomers are increased in which of the following conditions?
A. Primary fibrinolysis
B. DIC
C. Factor VIII deficiency
D. Fibrinogen deficiency
B. DIC
Which of the following is associated with multiple factor deficiencies?
A. An inherited disorder of coagulation
B. Severe liver disease
C. Dysfibrinogenemia
D. Lupus anticoagulant
B. Severe liver disease
B Most of the clotting factors are made in the liver. Therefore, severe liver disease results in multiple factor deficiencies. An inherited disorder of coagulation is commonly associated with a single factor deficiency. Lupus anticoagulant is directed against the phospholipid-dependent coagulation factors. Dysfibrinogenemia results from an abnormal fibrinogen molecule
Normal PT and APTT results in a patient with a poor wound healing may be associated with:
A. Factor VII deficiency
B. Factor VIII deficiency
C. Factor XII deficiency
D. Factor XIII deficiency
D. Factor XIII deficiency
D Factor XIII deficiency can lead to impaired wound healing and may cause severe bleeding problems. Factor XIII is a fibrin stabilizing factor that changes the fibrinogen bonds in fibrin polymers to stable covalent bonds. Factor XIII is not involved in the process of fibrin formation and, therefore, the PT and APTT are both normal
Fletcher factor (prekallikrein) deficiency may be associated with:
A. Bleeding
B. Thrombosis
C. Trhombocytopenia
D. Thrombocytosis
B. Thrombosis
B Fletcher factor (prekallikrein) is a contact factor. Activated prekallikrein is named kallikrein and is involved in activation of factor XII to XIIa. Like factor XII deficiency, Fletcher factor deficiency may be associated with thrombosis.